Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange Detected- Revision history updated: v3.3.2 added; v3.2.0 removed.SummaryDifference0.0%

- Check29 days agoChange DetectedNew Study Status entry (version 272) added on 2025-11-17; a government funding lapse notice dated 2025-10-31 was removed.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded new version entries 270 and 271, updated Study Status/Contacts/Locations, and removed entry 2025-09-22. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedNo substantive content changes were detected between the old and new screenshots; the page continues to display the trial record history.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check79 days agoChange DetectedPage now shows v3.1.0 with new study status/locations info; previous v3.0.2 and its date were removed.SummaryDifference0.6%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.